About ADL

This author has not yet filled in any details.
So far ADL has created 17 blog entries.

Precision Oncology Company Lantern Pharma’s Artificial Intelligence Approach

By |2019-08-05T20:11:57+00:00April 16th, 2018|

Precision Oncology Company Lantern Pharma's Artificial Intelligence Approach NEW YORK--(BUSINESS WIRE)--Lantern Pharma is applying Artificial Intelligence (AI) to tailor multiple promising precision drug programs to the right cancer patients through use of their RADRTM platform (Response Algorithm for Drug Rescue and Positioning).

Lantern Pharma Joins Genomics England to Advance Their Precision Oncology Platform

By |2019-08-05T20:07:07+00:00February 26th, 2018|

DALLAS--(BUSINESS WIRE)--Genomics England and Lantern Pharma, a clinical stage pharma company specializing in precision oncology using artificial intelligence, announced today that Lantern will join Genomics England’s Discovery Forum industry partnership. The partnership aims to translate groundbreaking research into innovative treatments, and ultimately patient benefit, as rapidly as possible.

Lantern Pharma: Precision Medicine Pioneers

By |2019-08-05T20:09:02+00:00March 2nd, 2017|

Lantern Pharma: Precision Medicine Pioneers According to a recent study, the overall success rate for drugs moving through clinical trials to approval by the US Food and Drug Administration is only about 10%. Even though cancer is the most closely studied disease for drug development, oncology drugs have the toughest time making their [...]